Clinical Trial Update: A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of HRS-8080 in combination with dalpiciclib for locally advanced or metastatic breast cancer resistant to adjuv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• HRS-8080

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Locally Advanced or Metastatic Breast Cancer | Phase 3 | Status: RECRUITING